Your browser doesn't support javascript.
loading
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms.
Aung, Thazin Nwe; Shafi, Saba; Wilmott, James S; Nourmohammadi, Saeed; Vathiotis, Ioannis; Gavrielatou, Niki; Fernandez, Aileen; Yaghoobi, Vesal; Sinnberg, Tobias; Amaral, Teresa; Ikenberg, Kristian; Khosrotehrani, Kiarash; Osman, Iman; Acs, Balazs; Bai, Yalai; Martinez-Morilla, Sandra; Moutafi, Myrto; Thompson, John F; Scolyer, Richard A; Rimm, David L.
Afiliação
  • Aung TN; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Shafi S; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Wilmott JS; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.
  • Nourmohammadi S; Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.
  • Vathiotis I; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Gavrielatou N; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Fernandez A; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Yaghoobi V; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Sinnberg T; University Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", 72076 Tübingen, Germany.
  • Amaral T; University Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", 72076 Tübingen, Germany.
  • Ikenberg K; Institute of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Khosrotehrani K; University of Queensland, UQ Diamantina Institute, Brisbane, QLD, Australia; Department of Dermatology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Osman I; Department of Medicine, Grossman School of Medicine, New York University, USA.
  • Acs B; Department of Pathology, Yale School of Medicine, New Haven, CT, USA; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Pathology and Cytology, Karolinska University Laboratory, Stockholm, Sweden.
  • Bai Y; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Martinez-Morilla S; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Moutafi M; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.
  • Thompson JF; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia; Charles Perkins C
  • Rimm DL; Department of Pathology, Yale School of Medicine, New Haven, CT, USA; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, USA. Electronic address: david.rimm@yale.edu.
EBioMedicine ; 82: 104143, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35810563
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: EBioMedicine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Holanda